Amgen Inc (AMGN):財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH3778FSA)
◆英語タイトル:Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3778FSA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2021年3月
◆ページ数:72
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:United States
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Amgen Inc (AMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to treat patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by direct-to-consumer channels such as print, television and online media. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Mar 05,2021: Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Mar 03,2021: Amgen announces 2021 second quarter dividend
Feb 03,2021: Amgen sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to help accelerate life science startups
Feb 02,2021: Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
Jan 22,2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amgen Inc – Key Facts
Amgen Inc – Key Employees
Amgen Inc – Key Employee Biographies
Amgen Inc – Major Products and Services
Amgen Inc – History
Amgen Inc – Company Statement
Amgen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Amgen Inc – Business Description
Business Segment: Human Therapeutics
Overview
Performance
Key Stats
Business Segment: Other Revenues
Overview
Performance
Geographical Segment: Rest of the world (ROW)
Performance
Geographical Segment: United States
Performance
R&D Overview
Amgen Inc – Corporate Strategy
Amgen Inc – SWOT Analysis
SWOT Analysis – Overview
Amgen Inc – Strengths
Amgen Inc – Weaknesses
Amgen Inc – Opportunities
Amgen Inc – Threats
Amgen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amgen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 03, 2021: Amgen sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to help accelerate life science startups
Feb 02, 2021: Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
Jan 22, 2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform
Jan 12, 2021: Amgen to showcase next frontier of innovation in lung cancer therapies at WCLC 2020
Jan 11, 2021: Amgen to achieve carbon neutrality by 2027
Jan 11, 2021: GRAIL announces collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate cancer early detection technology for minimal residual disease
Dec 17, 2020: Amgen awards two local biotech start-ups with Golden Ticket To LabCentral
Dec 16, 2020: Amgen to transfer listing of debt securities to Nasdaq
Dec 15, 2020: American College of Cardiology to collaborate with Amgen, Veradigm to optimize ACS care
Dec 10, 2020: AHF blasts Amgen over drug restrictions; Asks Biden Administration to sanction it and others
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amgen Inc, Key Facts
Amgen Inc, Key Employees
Amgen Inc, Key Employee Biographies
Amgen Inc, Major Products and Services
Amgen Inc, History
Amgen Inc, Other Locations
Amgen Inc, Subsidiaries
Amgen Inc, Joint Venture
Amgen Inc, Key Competitors
Amgen Inc, Ratios based on current share price
Amgen Inc, Annual Ratios
Amgen Inc, Annual Ratios (Cont...1)
Amgen Inc, Annual Ratios (Cont...2)
Amgen Inc, Interim Ratios
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amgen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Amgen Inc (AMGN):財務・戦略的SWOT分析(Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆